FLOW CYTOMETRY, CD 2

The Flow Cytometry CD2 Test is a specialized immunophenotyping assay used to detect and measure the expression of CD2, a cell surface glycoprotein primarily found on T lymphocytes and Natural Killer (NK) cells. CD2 plays an important role in immune cell activation, adhesion, and communication, making it a valuable marker in hematology and immunology diagnostics.

Flow cytometry enables rapid analysis of thousands of cells individually, providing detailed information about the presence and characteristics of CD2-positive cell populations. CD2 is commonly included in comprehensive flow cytometry panels used for the diagnosis, classification, and monitoring of leukemias, lymphomas, lymphoproliferative disorders, and immune system abnormalities.

Because CD2 is expressed on most mature T cells and NK cells, it serves as a useful marker for determining cell lineage and identifying abnormal lymphoid populations. The test is usually performed on peripheral blood, bone marrow aspirates, lymph node tissue, or other clinically relevant specimens.

Benefits of the Test

• Identifies T-cell and NK-cell populations
• Assists in leukemia and lymphoma diagnosis
• Supports immunophenotyping of lymphoid disorders
• Helps classify abnormal lymphocyte populations
• Assists disease monitoring and treatment planning
• Provides important diagnostic information

Why Doctors Recommend This Test

Doctors may recommend Flow Cytometry CD2 testing for:

• Suspected T-cell leukemia
• Suspected T-cell lymphoma
• NK-cell disorders
• Acute Lymphoblastic Leukemia (ALL) evaluation
• Lymphoproliferative disorder investigation
• Abnormal blood counts
• Bone marrow disorder assessment
• Comprehensive immunophenotyping studies

The test helps determine the lineage and characteristics of abnormal lymphoid cells.

Preparation Before Test

The test may require:

• Peripheral blood sample
• Bone marrow aspirate
• Lymph node tissue
• Body fluid specimen
• Other clinically appropriate samples

Preparation generally includes:

• No fasting is required
• Inform your physician about ongoing treatments
• Follow laboratory collection instructions

The specimen is analyzed using advanced multiparameter flow cytometry technology.

Normal Reporting Time

Results are generally available within 1 to 3 working days, depending on laboratory workflow and panel complexity.

Who Should Take This Test?

• Patients with suspected leukemia
• Individuals with suspected lymphoma
• Patients with abnormal lymphocyte counts
• Individuals undergoing bone marrow evaluation
• Patients with lymphoproliferative disorders
• Individuals referred by hematologists or oncologists

Flow Cytometry CD2 testing is an important component of modern hematological diagnostics and immune cell analysis.

Clinical Significance

CD2 expression is commonly observed in:

• Normal T Lymphocytes
• Natural Killer (NK) Cells
• T-cell Acute Lymphoblastic Leukemia (T-ALL)
• T-cell Lymphomas
• NK-cell Neoplasms
• Peripheral T-cell Lymphomas
• Other T-cell Lymphoproliferative Disorders

Abnormal CD2 expression patterns may help identify malignant lymphoid populations and support disease classification.

Important Note

CD2 is not interpreted as a standalone marker. It is typically evaluated alongside markers such as CD3, CD4, CD5, CD7, CD8, CD16, CD56, CD34, TdT, and CD45 to provide a complete immunophenotypic profile and ensure accurate diagnosis.